Catalent Inc (CTLT)
56.16
-0.31
(-0.55%)
USD |
NYSE |
Jun 25, 16:00
56.16
0.00 (0.00%)
Pre-Market: 20:00
Catalent Cash and Short Term Investments (Quarterly): 162.00M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 162.00M |
December 31, 2023 | 229.00M |
September 30, 2023 | 209.00M |
June 30, 2023 | 280.00M |
March 31, 2023 | 252.00M |
December 31, 2022 | 470.00M |
September 30, 2022 | 345.00M |
June 30, 2022 | 538.00M |
March 31, 2022 | 880.00M |
December 31, 2021 | 915.00M |
September 30, 2021 | 2.019B |
June 30, 2021 | 967.00M |
March 31, 2021 | 1.063B |
December 31, 2020 | 833.10M |
September 30, 2020 | 1.007B |
June 30, 2020 | 953.00M |
March 31, 2020 | 608.40M |
December 31, 2019 | 188.90M |
September 30, 2019 | 243.40M |
June 30, 2019 | 345.40M |
March 31, 2019 | 227.90M |
December 31, 2018 | 207.90M |
Date | Value |
---|---|
September 30, 2018 | 266.10M |
June 30, 2018 | 410.20M |
March 31, 2018 | 402.20M |
December 31, 2017 | 339.30M |
September 30, 2017 | 614.80M |
June 30, 2017 | 306.90M |
March 31, 2017 | 268.80M |
December 31, 2016 | 255.80M |
September 30, 2016 | 139.90M |
June 30, 2016 | 138.60M |
March 31, 2016 | 133.90M |
December 31, 2015 | 115.50M |
September 30, 2015 | 151.40M |
June 30, 2015 | 151.30M |
March 31, 2015 | 116.10M |
December 31, 2014 | 84.10M |
September 30, 2014 | 63.20M |
June 30, 2014 | 74.40M |
March 31, 2014 | 55.70M |
December 31, 2013 | 64.20M |
September 30, 2013 | 95.80M |
June 30, 2013 | 106.40M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
162.00M
Minimum
Mar 2024
2.019B
Maximum
Sep 2021
625.40M
Average
504.00M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Eli Lilly and Co | 2.586B |
Align Technology Inc | 898.91M |
Amgen Inc | 9.708B |
Gilead Sciences Inc | 4.718B |
Johnson & Johnson | 26.22B |